Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 27,733 | 13,487 | -1,956 | -1,330 | 31,011 |
| Depreciation Amortization | 120,090 | 88,994 | 56,325 | 28,152 | 116,048 |
| Income taxes - deferred | 1,369 | -720 | 1,173 | -3,504 | 4,208 |
| Accounts receivable | 10,999 | 10,992 | 4,100 | 3,849 | 3,065 |
| Other Working Capital | 83,470 | 66,095 | 38,719 | 21,213 | 73,324 |
| Other Operating Activity | 33,355 | 19,356 | 27,265 | 11,745 | 26,341 |
| Operating Cash Flow | $277,016 | $198,204 | $125,626 | $60,125 | $253,997 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -24,478 | -26,794 | -28,621 | 325 | -34,419 |
| PPE Investments | -118,153 | 26,455 | 15,356 | -3,276 | -237,119 |
| Other Investing Activity | 108,663 | 16,943 | 10,180 | 42 | 123,093 |
| Investing Cash Flow | $-33,968 | $16,604 | $-3,085 | $-2,909 | $-148,445 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,186,537 | 1,025,527 | 227,000 | 110,000 | 705,045 |
| Debt Repayment | -1,349,918 | -911,946 | -346,200 | -102,681 | -631,875 |
| Common Stock Issued | 4,163 | 3,397 | 229 | 113 | 1,285 |
| Common Stock Repurchased | -7,946 | N/A | N/A | N/A | -34,118 |
| Dividend Paid | -17,706 | -11,048 | -4,414 | -2,207 | -8,829 |
| Other Financing Activity | -65,012 | -11,515 | -2,156 | -1,061 | -139,987 |
| Financing Cash Flow | $-249,882 | $94,415 | $-125,541 | $4,164 | $-108,479 |
| Exchange Rate Effect | 97 | -15 | -189 | -77 | 183 |
| Beginning Cash Position | 73,239 | 73,239 | 73,239 | 73,239 | 75,983 |
| End Cash Position | 66,502 | 382,447 | 70,050 | 134,542 | 73,239 |
| Net Cash Flow | $-6,737 | $309,208 | $-3,189 | $61,303 | $-2,744 |
| Free Cash Flow | |||||
| Operating Cash Flow | 277,016 | 198,204 | 125,626 | 60,125 | 253,997 |
| Capital Expenditure | -219,450 | -49,223 | -32,930 | -27,810 | -318,811 |
| Free Cash Flow | 57,566 | 148,981 | 92,696 | 32,315 | -64,814 |